Cancer immunotherapy: an overview.
D000328:Adult; D000368:Aged; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000009:adverse effects / Q000627:therapeutic use; D004137:Dinitrochlorobenzene / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D008545:Melanoma / Q000276:immunology / Q000601:surgery / Q000628:therapy; D008875:Middle Aged; D009369:Neoplasms / Q000276:immunology / Q000517:prevention & control / Q000601:surgery / Q000628:therapy*; D009858:Oncogenic Viruses / Q000276:immunology; D011425:Propionibacterium acnes / Q000276:immunology; D012334:RNA, Neoplasm / Q000276:immunology; D014181:Transplantation Immunology; D014765:Viral Vaccines
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D001500:BCG Vaccine; D004137:Dinitrochlorobenzene; D012334:RNA, Neoplasm; D014765:Viral Vaccines